Alcohol metabolism.

Por Pagliaro, L, Pagliaro, A M
Publicado em 1992

Cocaine use and depression.

Por Pagliaro, L A, Jaglalsingh, L H, Pagliaro, A M
Publicado em 1992

Ultrasonic diagnosis of portal hypertension.

Por Cottone, M, D'Amico, G, Sciarrino, E, Maringhini, A, Pagliaro, L
Publicado em 1984

A modular phase I study of lenalidomide and paclitaxel in metastatic castration-resistant prostate cancer following prior taxane therapy

Por Mathew, P, Tannir, N, Tu, SM, Carter, CM, Bekele, NB, Pagliaro, L
Publicado no Cancer Chemother Pharmacol (2010)

Penile cancer: current therapy and future directions

Por Sonpavde, G., Pagliaro, L. C., Buonerba, C., Dorff, T. B., Lee, R. J., Di Lorenzo, G.
Publicado em 2013

Immunoblotting as a confirmatory test for antimitochondrial antibodies in primary biliary cirrhosis.

Por Provenzano, G, Diquattro, O, Craxì, A, Almasio, P, Pinzello, G, Marino, L, Fiorentino, G, Rinaldi, F, Pagliaro, L
Publicado em 1993

Delta agent infection in acute hepatitis and chronic HBsAg carriers with and without liver disease.

Por Craxì, A, Raimondo, G, Longo, G, Giannuoli, G, De Pasquale, R, Caltagirone, M, Patti, S, Squadrito, G, Pagliaro, L
Publicado em 1984

Ultrasound in the screening of patients with cirrhosis with large varices.

Por Cottone, M, Sciarrino, E, Marcenò, M P, Maringhini, A, D'Amico, G, Traina, M, Amuso, M, Pagliaro, L
Publicado em 1983

Vaccination of metastatic renal cell carcinoma patients with autologous tumour-derived vitespen vaccine: clinical findings

Por Jonasch, E, Wood, C, Tamboli, P, Pagliaro, L C, Tu, S M, Kim, J, Srivastava, P, Perez, C, Isakov, L, Tannir, N
Publicado em 2008

Outcome of patients with metastatic renal cell carcinoma treated with targeted therapy without cytoreductive nephrectomy

Por Richey, S. L., Culp, S. H., Jonasch, E., Corn, P. G., Pagliaro, L. C., Tamboli, P., Patel, K. K., Matin, S. F., Wood, C. G., Tannir, N. M.
Publicado em 2011

Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors

Por Nieto, Y., Tu, S.-M., Bassett, R., Jones, R. B., Gulbis, A. M., Tannir, N., Kingham, A., Ledesma, C., Margolin, K., Holmberg, L., Champlin, R., Pagliaro, L.
Publicado no Ann Oncol (2015)

Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors

Por Nieto, Y., Tu, S. -M., Bassett, R., Jones, R. B., Gulbis, A. M., Tannir, N., Kingham, A., Ledesma, C., Margolin, K., Holmberg, L., Champlin, R., Pagliaro, L.
Publicado no Ann Oncol (2015)

Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with pazopanib after progression during treatment with other targeted therapies

Por Matrana, M. R., Duran, C., Shetty, A., Xiao, L., Atkinson, B. J., Corn, P., Pagliaro, L. C., Millikan, R. E., Charnsangavej, C., Jonasch, E., Tannir, N. M.
Publicado em 2013

Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours

Por Fizazi, K, Prow, D M, Do, K-A, Wang, X, Finn, L, Kim, J, Daliani, D, Papandreou, C N, Tu, S-M, Millikan, R E, Pagliaro, L C, Logothetis, C J, Amato, R J
Publicado em 2002